Related Experiment Video
Updated: Nov 10, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Glucose Abnormalities and Inappropriate Weight Gain Predict Negative Pregnancy Outcomes After Gastric Bypass Surgery
H Gohier1, B Guyard-Boileau2, G Tuyeras3
1Nutrition Department, University Hospital Toulouse, CHU de Toulouse, Cedex 09, 31059, Toulouse, France.
Insights
Pregnancies after gastric bypass surgery show high risks for adverse outcomes. Monitoring interstitial glucose and maternal weight gain is crucial for improving outcomes in these high-risk pregnancies.
Area of Science:
- Bariatric surgery outcomes
- Maternal-fetal medicine
- Endocrinology
Background:
- Pregnancy following Roux-en-Y gastric bypass (RYGB) surgery is associated with increased risks of gestational diabetes mellitus, prematurity, and small for gestational age (SGA) infants.
- Understanding interstitial glucose (IG) profiles and maternal weight changes is essential for managing these pregnancies.
Purpose of the Study:
- To describe interstitial glucose (IG) profiles and weight changes during pregnancies after RYGB.
- To investigate the association between IG profiles, weight changes, and adverse pregnancy outcomes.
Main Methods:
- Retrospective analysis of 122 pregnancies post-RYGB.
- Continuous glucose monitoring (CGM) used to evaluate IG profiles.
- Logistic regression analysis to assess the influence of weight gain and IG on outcomes.
Main Results:
- 73% of women exhibited IG abnormalities (high or low glucose levels).
- Adverse outcomes included large for gestational age (LGA) infants (4%), SGA infants (20%), and prematurity (13%).
- Inappropriate maternal weight gain was independently associated with LGA and prematurity.
Conclusions:
- IG abnormalities and maternal weight gain significantly impact neonatal outcomes in pregnancies after RYGB.
- Close monitoring of IG and weight gain is recommended for pregnancies following RYGB surgery.
Purpose:
Pregnancy after gastric bypass (RYGB) surgery remains at high risk for gestational diabetes mellitus, prematurity, and small for gestational age infants (SGA). Our objective was to describe the interstitial glucose (IG) profiles and weight changes during such pregnancies, and the association of these factors with adverse pregnancy outcomes.
Material And Methods:
One hundred twenty two pregnancies were analyzed in a monocentric retrospective study. IG profiles were evaluated by continuous glucose monitoring for 4 days. Maternal (hypertension, hospitalizations, and caesarean section) and neonatal outcomes (prematurity, weight for gestational age, hospitalizations, and malformations) were recorded. A logistic stepwise regression model assessed the influence of weight gain and impaired IG on pregnancy outcomes.
Results:
Pregnancies occurred 33 (SD 21 months) after surgery. 73% of the women had IG abnormalities (55% with an increased % of time >140 mg/dl and 69% with an increased % of time <60 mg/dl). Five (4%) children were large for gestational age (LGA), 24 (20%) were SGA and 16 (13%) were born prematurely. There were 3 malformations but no stillbirth. LGA was associated with a high % of time >140 mg/dl and an excessive maternal weight gain. Prematurity was associated with a high % of time <60 mg/dl and an insufficient maternal weight gain. In the multivariate analysis, inappropriate weight gain explained LGA and prematurity independently. SGA was associated with a shorter % of time <60 mg/dl.
Conclusion:
The relationship between IG abnormalities and/or maternal weight gain and neonatal outcomes in pregnancies after RYGB, suggests a careful monitoring of these parameters.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

